Literature DB >> 3379105

Isolation and visualization of Met-72-positive, metastatic variants present in B16 melanoma tumor masses.

N P Parratto1, A K Kimura.   

Abstract

Metastatic variants of the B16 melanoma displaying high experimental metastatic potential have been shown to express high levels of a 72,000-dalton glycoprotein (Met-72) on their cell surface (Kimura AK, Xiang J: J Nat Can Inst 76:1247-1253, 1986). Monoclonal antibodies (MoAb) directed against the Met-72 determinant have been used in this study as immunohistochemical reagents on preparations of fresh B16 melanoma tumors and their metastases. These immunohistochemical analyses have utilized frozen sections, impression smears, and cytospin preparations of fresh tumors harvested at various time points during tumor growth, to view the presence and location of Met-72-positive metastatic variants within tumor masses. Biotinylated anti-Met-72 MoAbs were reacted with freshly dissociated tumor cells from a B16 melanoma ovarian metastasis. These cells were then reacted with fluorescein isothiocyanate (FITC)-streptavidin and analyzed by flow cytometry. A discrete population of positively staining cells was detected and isolated by cell sorting techniques. Met-72-positive cells were then cloned and reanalyzed after several weeks of in vitro expansion and found to have high experimental metastatic potential to ovaries. Frozen sections of subcutaneous tumors and their metastases were analyzed by immunoperoxidase techniques. A consistent finding in these studies has been that the few tumor cells which showed high intensity of Met-72 staining were positioned perivascularly and at the invading front of B16 melanoma tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379105     DOI: 10.1002/jcb.240360311

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques.

Authors:  K I Bland; A K Kimura; D E Brenner; M A Basinger; M Hirsch; I F Hawkins; K K Pierson; E M Copeland
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

2.  Synthesis and expression of metastasis-associated, Met-72/83 antigens.

Authors:  J H Xiang; A K Kimura; J P Hansen
Journal:  Clin Exp Metastasis       Date:  1988 Nov-Dec       Impact factor: 5.150

3.  Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours.

Authors:  P A van Dam; J V Watson; D G Lowe; H Cox; M Curling; J H Shepherd
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.